Geert Cauwenbergh, President & CEO at RXi Pharmaceuticals Corp (RXII), bought 10,000 shares at $2.19 ($22K) on 2014-09-15, disclosed to the SEC on 2014-09-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.18 | 5,000 | $11K | 49.9% |
| 2 | $2.19 | 2,000 | $4K | 20.0% |
| 3 | $2.19 | 3,000 | $7K | 30.1% |
| Total | $2.19 avg | 10,000 | $22K | 100% |
| Filing → |
| RXII | BUY | 2017-06-22 | $6K | — | Filing → |
| RXII | BUY | 2017-04-26 | $7K | — | Filing → |
| RXII | BUY | 2017-03-20 | $8K | — | Filing → |